Upgrade to SI Premium - Free Trial

Abbvie (ABBV): IPR Victory Translates Into A 36% PT Increase - Cowen

September 11, 2017 6:16 AM
Cowen analyst, Steve Scala, reiterated his Outperform rating on shares of Abbvie (NYSE: ABBV) and raised his price target to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst PT Change

Next Articles